tbuckley/cabot-search huggingface dataset:
P2.10B.05 Renal Toxicity in Patients with Non-Small Cell Lung Cancer Receiving Maintenance Therapy with Pemetrexed and Pembrolizuma
Authors: U.M. Weber, A.G. Nicklawsky, B.A. Yoder, E.L. Schenk, P.A. Bunn, D.R. Camidge, T. Patil
Journal: Journal of Thoracic Oncology (2024)
P2.11A.17 Impact of Mutation Class and Smoking Status in BRAF-Mutant Non-Small Cell Lung Cancer (NSCLC) Treated with Immune Checkpoint Inhibitors (ICI)
Authors: J.A. Marin-Acevedo, S.V. Bandikatla, R. Thapa, S. Puri, D.-T. Chen, K. Hicks, J. Gray
Journal: Journal of Thoracic Oncology (2024)
P2.14A.05 Validity of Simple Thymomectomy for Clinical Stage I Thymoma without Myasthenia Gravis: A Propensity Score-Matched Analysis
Authors: T. Hishida, T. Suzuki, S. Omura, Y. Okubo, K. Masai, K. Kaseda, K. Asakura
Journal: Journal of Thoracic Oncology (2024)
P2.11B.06 BIRC5 Expression Correlated with Immunosuppressive Phenotype and Predicted Inferior Response to Immunotherapy in LUAD
Authors: S. Yang, X. Liu, S. Mao, C. Shao, X. Li, C. Zhao, Y. Wang, Q. Fang, B. Chen, F. Wu, X. Chen, X. Chen, J. Yu, S. Ren
Journal: Journal of Thoracic Oncology (2024)
MA18.05 Effectiveness of NELSON vs PLCOm2012 Lung Cancer Screening Eligibility Criteria: Final Analysis of the Prospective German HANSE Study
Authors: J. Vogel-Claussen, B. Bollmann, K. May, S. Stiebeler, S. Dettmer, A. Faron, A. Kuhlmann, G. Schmid-Bindert, R. Kaaks, J. Barkhausen, S. Bohnet, M. Reck
Journal: Journal of Thoracic Oncology (2024)
P2.14B.01 [DREAM] Double Lung Transplant Registry Aimed for Lung-limited Malignancies - A Prospective Registry Study for Medically Refractory Cancers
Authors: Y.K. Chae, L.I.-Y. Chung, T. Demir, C. Moloney, B. Sanson, R. Dwyer, C.M. Jung, R. Tomic, A. Bharat
Journal: Journal of Thoracic Oncology (2024)
P2.10B.02 Cutoff Determination for C-met Protein Overexpression by VENTANA MET (SP44) IHC to Determine Teliso-v Eligibility in NSCLC
Authors: N. Zhang, Y. Sun, P.J. Ansell, A.T. Mistry, M.M. Li, A.G. Hotson, C.K. Ratajczak, D. Smith
Journal: Journal of Thoracic Oncology (2024)
P2.10A.06 Phase 3 TroFuse-004 Study: Sac-TMT vs Chemotherapy for Previously Treated Advanced NSCLC with EGFR/Other Genomic Alterations
Authors: E.B. Garon, F. Cappuzzo, M.-J. Ahn, S. Lu, T. Kato, E. Felip, P. Cheema, N. Girard, M. Shamoun, G. Wang, B. Zhao, R. Hui
Journal: Journal of Thoracic Oncology (2024)
P2.10B.07 Chemotherapy in Combination with Anti-PD1 in PD-L1-Negative Non-Small Cell Lung Cancer Patients: A Single-Center Experience
Authors: J. Marchal Cabrera, S. Sequero López, E.I. Morcillo Calero, Ó. Valle Cárcel, E. Mañas Mora
Journal: Journal of Thoracic Oncology (2024)
P1.03D.04 Circulating APOBEC Signature as a Non-Invasive Biomarker Delineating Potential Responder to Neoadjuvant Immunotherapy for IIIA-N2 NSCLC
Authors: C. Wu, Y. Huang, S. Li, L. Hou, T. Hu, T. Sun, J. Wang, X. Li, C. Zhu
Journal: Journal of Thoracic Oncology (2024)
MA18.07 Missing Variables and the Utility of Lung Cancer and Lung Nodule Risk Calculators
Authors: W. Liao, A.T. Matthews, J.U. Goss, T.U. Qureshi, S.U. Peppers, A.U. Harris, A.U. Porter, K.U. Dortch, C. Fehnel, K. Tonkin, M.A. Ray, A. Mehrotra, S. Ely, M.P. Smeltzer, R.U. Osarogiagbon
Journal: Journal of Thoracic Oncology (2024)
P2.05C.01 Pathologic Nodal Staging Reporting Quality: A Multi-Center Assessment of NSCLC Trends Over Time &amp; Key Reporting Parameters
Authors: H. Tupper, J. Santhakumar, K. Burapachaisri, R. Jackson, Z. Islas, K.C. Banks, V. Sarovar, A. Sun, R.K. Wile, K.E. Barnes, L.C. Sakoda, J.B. Velotta
Journal: Journal of Thoracic Oncology (2024)
P2.11A.06 Tumor-Informed ctDNA Status Guiding 1st-line Immuno-Chemotherapy in Advanced NSCLC: CHOICE-01 Retrospective Analysis
Authors: Z. Wang, J. Zhong, J. Xu, R. Wan, H. Bai, J. Duan, X. Mi, W. Xie, Y. Xu, C. Li, G. Wang, S. Cai, J. Wang
Journal: Journal of Thoracic Oncology (2024)
MA19.04 Teriflunomide in Vitro or Leflunomide in Vivo Treatment Increases the Efficacy of Lurbinectedin in SCLC
Authors: T. Mirzapoiazova, L. Tseng, I. Mambetsariev, H. Li, B. Armstrong, S. Singhal, P. Kulkarni, R. Salgia
Journal: Journal of Thoracic Oncology (2024)
P2.07A.02 The Effect of EGFR Mutation on Adjuvant Tegafur/Uracil for Patients with Non-Lymph Node Metastatic NSCLC (&gt; 2 Cm)
Authors: T. Miyoshi, K. Aokage, S-i. Watanabe, H. Ito, N. Sakakura, M. Mun, M. Yamashita, Y. Ohde, T. Aoki, W. Nishio, M. Taguri, M. Tsuboi
Journal: Journal of Thoracic Oncology (2024)
P2.07C.01 LCMC3: Clinical Utility of Suvmax on Preoperative 18F-FDG PET-CT in Resectable NSCLC Treated with Neoadjuvant Atezolizumab
Authors: R. Merritt, G.A. Patterson, E.M. Toloza, J.M. Lee, D.J. Raz, F. Baciewicz, M. Weyant, D. Molena, J. Isbell, J. Kim, H.I. Pass, P.A. Bunn, B.E. Johnson, M.G. Kris, D.J. Kwiatkowski, I.I. Wistuba, I. Bara, G. Gasior, K. Schulze, E. Brandão, P.J. Kneuertz, F. Detterbeck, B. Kozower, J.P. Fontaine, B. Park, C.J. McNamee, J.D. Blasberg, D.J. Finley, A. Nicholas, A. Johnson, D.P. Carbone, V.W. Rusch
Journal: Journal of Thoracic Oncology (2024)
P2.11A.02 Proteomics-Based Target Identification for Optimizing Bispecific Antibody Use in NSCLC
Authors: A.A. Khosla, E. Lin, M.S. Kumar, J. Deshane, K. Goliwas, S. Ponnazhagan, I. Jaiyesimi, A. Desai
Journal: Journal of Thoracic Oncology (2024)
P2.11A.12 Machine Learning-Based Clinicogenomic Prediction of Response to PD-(L)1 Inhibition in KRAS Altered Non-Small Cell Lung Cancer
Authors: D. Boiarsky, L. Hong, B. Ricciuti, A. Cooper, M. Saad, A. Elkrief, A. Di Federico, M. Aminu, W. Rinsurongkawong, J. Lewis, A. Vaporciyan, X. Le, J.J. Lee, J. Luo, J. Wu, M. Negaro, D. Gibbons, J. Heymach, F. Skoulidis, A. Schoenfeld, M. Awad, J. Zhang, N. Vokes
Journal: Journal of Thoracic Oncology (2024)
P2.07B.02 Is Wedge Resection Really Enough for the Treatment of Patient with Stage I Non-Small Cell Lung Cancer? A SEER Database Analysis
Authors: L. Ventura, S. Tenconi, J. Rao, W. Pradeep, A. Kar, J. Edwards, W. Fang, D. Waller
Journal: Journal of Thoracic Oncology (2024)
P2.10B.04 Paclitaxel Liposome Combined with Immunotherapy in the First-Line Treatment of Advanced NSCLC: A Multicenter Real-World Study
Authors: L. Jiang, D. Zheng, J. Ni, H. Ding, Y. Zhao, W. Heng, Y. Shang, X. Cai, J. Yan, J. Wang, J. Guo, X. Tan, X. Hong, J. Zhang
Journal: Journal of Thoracic Oncology (2024)
P2.10B.06 Improvements in Survival Outcomes of Large Cell Carcinoma Over Past Two Decades (2000-2020)
Authors: A. Sood, J. Elengickal, A. Sangari, S.H. Peketi, L. Hou, W. Aung, M. Locke, X. Zou, N. Seetharamu
Journal: Journal of Thoracic Oncology (2024)
P2.07B.07 Multi-Institutional Retrospective Analysis of Segmentectomy Versus Lobectomy for Non-Small Cell Lung Cancer Larger Than 3 cm in Diameter
Authors: Y. Kudo, Y. Shimada, T. Mimae, M. Hagiwara, M. Kakihana, T. Ohira, T. Nagashima, Y. Miyata, H. Ito, M. Okada, N. Ikeda
Journal: Journal of Thoracic Oncology (2024)
MA15.09 LCMC3: Long-Term Disease-Free and Overall Survival and their Association with ctDNA after Neoadjuvant Atezolizumab for NSCLC
Authors: D.H. Owen, J.E. Chaft, E.B. Haura, E. Toloza, S.N. Waqar, G.A. Patterson, D. Finley, J. Blasberg, D. Raz, R. Salgia, J.M. Lee, P. Bunn, I. Wistuba, D.J. Kwiatowski, F.R. Hirsch, A. Gopalakrishnan, A. Batra, E. Brandão, J.M. Grindheim, A. Nicholas, A. Johnson, K. Schulze, E. Shum, M. Nagasaka, J. Gainor, C.J. McNamee, B.E. Johnson, M.G. Kris, V.W. Rusch, D.P. Carbone
Journal: Journal of Thoracic Oncology (2024)
MA19.05 Dynamic Immune Profile of Peripheral Blood Predicts Immunotherapy Efficacy and Prognosis in Small Cell Lung Cancer
Authors: L. Wu, J. Wang, B. Chen, X. Pu, J. Li, Y. Xu, L. Xu, Y. Kong, F. Xu, K. Li, Q. Wang, L. Liu
Journal: Journal of Thoracic Oncology (2024)
MA16.04 Radiomic Biomarkers Predict Response to Immunotherapy Rechallenge in Recurrent NSCLC after Chemoradiation and Durvalumab
Authors: L. Delasos, M. Khorrami, M. Zokaei Nikoo, P.D. Patil, M.A. Shapiro, K.A. Hassan, J. Stevenson, A.A. Adjei, A. Madabhushi, N.A. Pennell
Journal: Journal of Thoracic Oncology (2024)
MA17.07 Durvalumab Plus Anlotinib Versus Durvalumab as Maintenance Treatment in ES-SCLC (DURABLE): A Randomized, Phase 2 Trial
Authors: B. Han, B. Zhang, R. Zhong, C. Shi, T. Chu, W. Zhang, H. Wang, Y. Zhao, G. Xin, Z. Zhang, W. Su, J. Li, H. Zhong
Journal: Journal of Thoracic Oncology (2024)
MA17.08 Safety and Efficacy of Tifcemalimab Combined with Toripalimab in Refractory Extensive Stage Small Cell Lung Cancer
Authors: Y. Cheng, J. Wang, Y. Yu, Q. Wang, R. Yang, D. Lv, B. Xia, T. Yi, C. Li, X. Wang, W. Zhang, L. Han, X. Liu, M. Su, M. Shen, J. Xu, J. Wang, L. Zhang
Journal: Journal of Thoracic Oncology (2024)
MA17.09 Efficacy and Safety of Tislelizumab Plus Anlotinib and 2-Cycle Irinotecan as Second-Line Treatment for ES-Small Cell Lung Cancer(ESTAIL)
Authors: x. chen, H. Zhang, W. Li, Y. Qu, X. Qu, R. Zhou, H. Hong, Y. Zhu, X. Chai, L. Liu, Y. Li
Journal: Journal of Thoracic Oncology (2024)
MA15.13 Furmonertinib as Adjuvant Therapy for Completely Resected Stage IA with High-Risk Factors and IB NSCLC Patients with EGFR Mutations
Authors: R. Geng, Y. Chen, J. Miao, H. Liu, Y. Qin, Z. Han, S. Li, Y. Guan, H. Wu, Y. Zhao, Y. Wang
Journal: Journal of Thoracic Oncology (2024)
P1.01C.04 Key Stakeholder Priorities on Embedding Smoking Cessation Into Lung Cancer Screening: National Australian Consensus Workshop
Authors: S. York, G. Bartlett, N.J. Harrison, H.M. Marshall, E. Stone, S. McCullough, C. Paul, B. Bonevski, J. Rhee, M. Weber, A. McWilliams, F. Brims, K.P. Lim, T. Byrne, N.M. Rankin
Journal: Journal of Thoracic Oncology (2024)
P1.01A.01 The INHERIT Study - Investigating Hereditary Risk in Thoracic Cancers (NCT05587439)
Authors: J. LoPiccolo, V.G. Williamson, D.R. Koeller, D.R. Haradon, A. Harper, V. Kotait, E. Izzo, A. Ciupek, B. Addario, J.C. King, R. Erwin, C.A. Granville, J.E. Garber, P.A. Jänne
Journal: Journal of Thoracic Oncology (2024)
P1.02B.01 Mirnome Functional Profiling of Non-Small Cell Lung Cancer Identified New Mechanisms of PD-L1 Regulation
Authors: R. Cuttano, M.K. Afanga, V. Melocchi, E. Dama, M. Bizzarri, C. Carbonelli, P. Graziano, F. Bianchi
Journal: Journal of Thoracic Oncology (2024)
MA17.05 Longitudinal MRD Monitoring Enhances Prognosis Prediction in 105 Patients with Limited-Stage SCLC Receiving Concurrent Chemoradiotherapy
Authors: y. yang, J. Zhao, Y. Wu, T. Zhang, J. Wang, L. Deng, M. Zhu, X. Zhao, Q. Ou, Y. Shao, L. Wang, N. Bi
Journal: Journal of Thoracic Oncology (2024)
P1.01B.05 Real-World Data on 3-Year Survival in Non-Small Cell Lung Cancer (NSCLC): Results from 3 French Nationwide Cohorts from 2000 To 2020
Authors: D. Debieuvre, B. Delclaux, G. De Chabot, F. Al Freijat, J. Le Treut, J.-Y. Tavernier, O. Leleu, P. Kuntz, S. Loutski, K. Fouet, J.M. Dot, M. Popa, A. Belle, C. Vincent, S. Julien, C. Perrin, N. Banciu, J. Virally, F. Lamotte, H. Morel
Journal: Journal of Thoracic Oncology (2024)
OA09.04 Osimertinib with or without SRS for Brain Metastases from EGFRm NSCLC: Pooled Analysis of Two RCTs
Authors: C. Ho, Y.Y. Soon, A. Nichol, K. Robledo, A. Sahgal, M. Pinkham, B. Melosky, Y. Huang, A. Parmar, B. Solomon, I.W.K. Tham, A. Sacher, J.C.S. Tey, I. Menjak, C.N. Leong, D. Shultz, W.Y. Koh, M. Doherty, Y. Ang, J. Low, C. Yong, M.C. Lim, A.P. Tan, C.K. Lee, R. Soo, S. Lefresne, F. Hegi-Johnson
Journal: Journal of Thoracic Oncology (2024)
MA11.07 Pembrolizumab Plus Maintenance Olaparib as First-Line Therapy for Metastatic Nonsquamous NSCLC: Phase 3 KEYLYNK-006 Study
Authors: J. Gray, M. Schenker, M.A.N. Sendur, S.-W. Kim, V. Leonova, D. Kowalski, T. Kato, R. Orlova, J.C.-H. Yang, A. Langleben, M.-K. Breyer, A. Ungureanu, M. Perez Mak, F. De Angelis, Z. Zimmer, B. Zhao, M. Shamoun, T.M. Kim
Journal: Journal of Thoracic Oncology (2024)
MA03.07 Outcomes of Older Patients in CALGB 140503 (Alliance): Lobar vs Sublobar Resection for Peripheral Stage IA Non-Small Cell Lung Cancer
Authors: A.K. Ganti, B. Damman, X. Wang, T.E. Stinchcombe, N. Altorki
Journal: Journal of Thoracic Oncology (2024)
MA02.09 An Effective Multimodel Based on Cell-Free DNA Methylation for Risk Stratification of Pulmonary Nodules
Authors: W. Liang, J. Tao, C. Cheng, H. Sun, Z. Ye, S. Wu, Y. Guo, J. Zhang, Q. Chen, D. Liu, L. Liu, H. Tian, N. Zhong, J.-B. Fan, J. He
Journal: Journal of Thoracic Oncology (2024)
MA15.11 Neoadjuvant Sintilimab plus Chemotherapy in EGFR-mutant NSCLC Followed by adjuvant Osimertinib or Observation: A Phase II CTONG2104 Trial
Authors: C. Zhang, B-y. Jiang, L-x. Yan, Z-y. Chen, C. Lv, Y-s. Li, S. Dong, R-q. Liao, X-n. Yang, Q. Zhou, Y.-L. Wu, W-z. Zhong
Journal: Journal of Thoracic Oncology (2024)
P1.01A.02 Monitoring Inflammatory Response Secondary to Air Pollution Exposure Through Volatile Organic Compounds
Authors: R.L. Myers, A. Smolinska, C. Bartolomeu, F. Ricciardi, B. O'Brien, S. Thompson, M. Allsworth, B. Boyle, C. Carlsten, S. Lam
Journal: Journal of Thoracic Oncology (2024)
MA01.09 Definitive Chemoradiation Followed by Immunotherapy vs. Surgery for cT4N2M0 NSCLC: A Contemporary Nationwide Analysis.
Authors: J.H. Rodriguez-Quintero, R. Jindani, R. Zhu, B. Cohen, M.K. Kamel, N. Mahajan, M. Vimolratana, N. Chudgar, B. Stiles
Journal: Journal of Thoracic Oncology (2024)
OA17.03 Missed Opportunities for Early Lung Cancer Detection in a Multi-Disciplinary Thoracic Oncology Clinic Cohort
Authors: W.T. Liao, A.T. Patel, F. Caro, J. Roma, W. Marshall, J. Goss, C. Fehnel, A. Mehrotra, O. Ogbeide, P. Lammers, k. Tonkin, J. Machin, M. Ray, M.P. Smeltzer, R.U. Osarogiagbon
Journal: Journal of Thoracic Oncology (2024)
MA03.11 Postoperative Complications Compromised Disease-Free and Recurrence-Free Survival in CALGB 140503 Trial Patients
Authors: D.L. Miller, X. Wang, B. Damman, J. Mentlick, R. Landreneau, D. Wigle, D. Jones, M. Conti, A. Ashrafi, M. Liberman, J. Port, M. de Perrot, J. Mitchell, R. Keenan, T. Bauer, T. Stinchcombe, N. Altorki
Journal: Journal of Thoracic Oncology (2024)
OA18.04 Pembrolizumab Plus Lenvatinib in Second-Line Pleural Mesothelioma Patients: A Single Arm Phase II Study (PEMMELA Cohort 2)
Authors: L.H. Douma, V.v.d. Noort, F. Lalezari, J.F. de Vries, M. Vermeulen, B. Schilder, I. Smesseim, P. Baas, K. Monkhorst, J.A. Burgers, C.J. de Gooijer
Journal: Journal of Thoracic Oncology (2024)
MA12.07 Amivantamab Plus Lazertinib vs Osimertinib in First-Line, EGFR-Mutant Advanced NSCLC: Patient-relevant Outcomes from MARIPOSA
Authors: D. Nguyen, B. Besse, B.C. Cho, S.-H. Lee, K.H. Lee, S. Lu, Y. Cheng, Y. Yao, N. Girard, C.-C. Lin, E. Felip, A. Aguilar, C. Charoentum, F.J.S.M. Cruz, M. Majem, C.S. Lim, H. Akamatsu, H. Hayashi, J.C.-H. Yang, R. Kowalyszyn, K. Tiscoski, F. Franke, D. Ponomarenko, C. Arslan, M. Forster, D. Urban, D. Misch, A. Delmonte, L.V.G. Montes, S.M. Gadgeel, M. Cruz-Correa, J. Peguero, S. Rousey, Y. Gaffar, S. Owen, J. Schuchard, J. Diels, J. Sermon, T. Sun, M. Ennis, E. Fennema, M. Daksh, S. Sethi, J.M. Bauml, M.R. Garcia Campelo
Journal: Journal of Thoracic Oncology (2024)
MA04.07 Low-Dose Computed Tomography Lung Cancer Screening Participants Live Longer Than Matched Controls, A Case-Control Study
Authors: R. Dziedzic, P. Kanyion, B. Koń, M. Kruk, E. Szurowska, T. Zdrojewski, J. Polańska, W. Rzyman
Journal: Journal of Thoracic Oncology (2024)
MA16.08 Impact of Site of CAN-2409 Injection Plus Continued Immune Checkpoint Inhibitor (ICI) In CI-resistant stage III/IV NSCLC
Authors: D. Sterman, C. Aggarwal, E.R. Alesi, F. Maldonado, R. Mehra, C. Bestvina, J.S. Reisenauer, L.K. Swartz, S. Puri, O. Ibrahim, G. Eapen, C. Duault, D.M. Del Valle, S. Kim-Schulze, E. Gonzalez-Kozlova, S. Gnjatic, A. Manzanera, L. Lopez, J. Dwyer, S. Rao, G. Nichols, F. Barone, P.P. Tak
Journal: Journal of Thoracic Oncology (2024)
OA16.03 Telisotuzumab Vedotin in Asian Patients with C-Met Protein-Overexpressing Non-Squamous EGFR WT NSCLC: Results from LUMINOSITY
Authors: H. Horinouchi, J.-Y. Hung, Z.-Y. Ding, S.-H. Lee, C. Liu, J. Looman, C. Ratajczak, H. Alhasani, M. Li, S. Xia, S. Lu
Journal: Journal of Thoracic Oncology (2024)
MA15.03 Surveillance with [18F]FDG PET/CT of Lung Cancer after Curative Therapy; First Results of a Randomized Trial (SUPE_R)
Authors: K. Guldbrandsen, M. Bloch, K. Skougaard, B.S. Sørensen, J. Fledelius, L.S. Mortensen, H.M. Nellemann, A. Højsgaard, M. Krakauer, S.H. Schwaner, P.M. Gørtz, S. Borissova, M. Pøhl, L.B. Ahlborn, E. Albrecht-Beste, R.H. Petersen, A.L. Nielsen, C.B. Laursen, L.H. Land, E. Jakobsen, Z. Saghir, P.C. Holdgaard, O. Hilberg, L.B. Møller, M. Dahl, M.S. Frank, J.H. Ehlers, J.M. Grüner, S.S. Nielsen, C. Kristiansen, T. McCulloch, M.S. Christophersen, T.L. Rasmussen, U. Bødtger, M.N. Lonsdale, C.N. Meyer, O. Gerke, J. Mortensen, T.R. Rasmussen, B.M. Fischer
Journal: Journal of Thoracic Oncology (2024)
OA09.03 Randomized, Open-Label, Phase III Study of SAF-189s Versus Crizotinib in First-Line ALK-Positive Advanced Non-Small Cell Lung Cancer (NSCLC)
Authors: A. Xiong, N. Yang, X. Dong, Y. Fan, L. Xu, P. Pan, Y. Yu, J. Zhou, Y. Li, J. Cui, M. Wang, Y. Zhang, R. Chen, H. Niu, H. Qin, S. Guo, D. Huang, H. Wu, W. Yao, Z. Zhang, J. Fang, Y. Fang, M. Li, L. Liu, W. Su, Z. Wu, X. Wang, H. Liu, J. Hu, X. Xiang, C. Zhou
Journal: Journal of Thoracic Oncology (2024)
OA13.05 I-SABR-SELECT: A Radiomics-Based Model for Personalized Immunotherapy for Early-Stage Non-Small Cell Lung Cancer
Authors: M.B. Saad, E. Showkatian, Q. Al-Tashi, M. Aminu, X. Xinyan, M. Qayati Mohamed, M. Salehjahromi, S.J. Sujit, S.H. Lin, Z. Liao, S. Gandhi, D. Qian, D.A. Jaffray, C. Chung, N. Vokes, J. Zhang, J.V. Heymach, J. Wu, J.Y. Chang
Journal: Journal of Thoracic Oncology (2024)
MA08.08 Association of FDG-PET/CT Findings with Sufficient Amount of Tissue Samples for Gene Panel Testing in TBB/TBNA
Authors: A. Tamura, R. Ko, H. Kenmotsu, T. Kawata, S. Matsuda, M. Morita, M. Sekikawa, K. Doshita, M. Yabe, H. Kodama, K. Miura, Y. Iida, N. Mamesaya, H. Kobayashi, K. Wakuda, A. Ono, T. Naito, H. Murakami, H. Nokihara, M. Hojo, T. Takahashi
Journal: Journal of Thoracic Oncology (2024)
MA11.09 Phase II Trial of Atezolizumab Plus Cobimetinib in PD-(L)1 Inhibitor Resistant NSCLC: NCI ETCTN Study 10166
Authors: A. Saltos, R. Hall, M. Tan, C. Kim, A. Saxena, K. He, H. Mamdani, T.W. Lycan, L. Villaruz, M. Khalil, R. Aljumaily, T. Tanvetyanon, R.D. Gentzler, B. Ma, D. Ozisik, J.A. Murray, S.V. Liu
Journal: Journal of Thoracic Oncology (2024)
OA16.04 Preliminary Results from a FIH Study of GQ1005, A Novel HER2-ADC, in Patients with Advanced HER2-Expressing Solid Tumors and HER2-Mutated NSCLC
Authors: C. Zhou, B. Yang, Y. Sun, W. Zhuang, L. Wang, T. Deng, X. Li, J. Zhang, Q. Wang, W. Li, Y. Yang, Q. Song, A. Xiong
Journal: Journal of Thoracic Oncology (2024)
MA14.12 Characterization of Sexual Dysfunction in Patients with Lung Cancer Undergoing Oncological Management: Results from the LUDICAS Study
Authors: A.V. Ospina Serrano, E. Azkona, P. Guillén Sentís, F. Aparisi, R. López Castro, P. Cruz, A. Valdivia, P. Cordeiro, A. Olivares Hernández, M. Dómine, M. Antoñanzas Basa, A. Blasco, D. Peralta, M. Sereno Moyano, A. Cardeña Gutiérrez, R. Romão, B. Losada Vila, A. Avendaño, N. Arango, P. Ramos, M. Guirado Risueño, S. Muñoz, J. Cuello, B. Campos Balea, I.C. Triana, M. Provencio
Journal: Journal of Thoracic Oncology (2024)
MA12.04 FLAURA2: Impact of Tumor Burden on Outcomes of 1L Osimertinib ± Chemotherapy in Patients with EGFR-mutated Advanced NSCLC
Authors: N. Valdiviezo, J.E. Gray, P.A. Jänne, K. Kobayashi, J.C.-H. Yang, Y. Cheng, C.K. Lee, S. Sugawara, Y. Yu, T.M. Kim, S. Taggart, M. Albayaty, D. Ghiorghui, D. Planchard
Journal: Journal of Thoracic Oncology (2024)
OA11.04 Volrustomig + platinum doublet chemotherapy (CTx) in first-line non-small cell lung cancer (NSCLC): Phase 1b trial update
Authors: D.R. Spigel, M.-J. Ahn, M. Majem, L. Medina Rodríguez, K.H. Lee, E. Carcereny, A.A. Hernández, A. Insa, E.K. Cho, B. Besse, S.Y. Rha, J. Weiss, M. D'Arcangelo, S.-A. Im, S.-W. Kim, B.A. Carneiro, S.M. Gadgeel, P. Mitchell, J.M. Asare, S.D. Gainer, I. Achour, D.S. Subramaniam, E. Felip
Journal: Journal of Thoracic Oncology (2024)
MA12.03 FLAURA2: Resistance, and Impact of Baseline TP53 Alterations in Patients Treated With 1L Osimertinib ± Platinum-Pemetrexed
Authors: J.C. Yang, J. Robichaux, D. Planchard, K. Kobayashi, C.K. Lee, S. Sugawara, T.-Y. Yang, T.M. Kim, S.-W. Kim, N. Yanagitani, A. Markovets, P.J. Bhetariya, L. Poole, Y. Rukazenkov, R. Hartmaier, P.A. Jänne
Journal: Journal of Thoracic Oncology (2024)
OA11.06 Cemiplimab Monotherapy for First Line Advanced NSCLC Patients with PD-L1 Expression ≥50%: 5-y Outcomes of EMPOWER-Lung 1
Authors: S. Kilickap, A. Sezer, M. Özgüroğlu, M. Gumus, I. Bondarenko, M. Gogishvili, M. Nechaeva, M. Schenker, I. Cicin, H.G. Fuang, Y. Kulyaba, K. Zyuhal, R.-I. Scheusan, A. Baramidze, M.C. Garassino, Y. Li, X. Jia, M. Kaul, J. Perez, F. Seebach, I. Lowy, J.-F. Pouliot, E. Kim, P. Rietschel, H. Magnan
Journal: Journal of Thoracic Oncology (2024)
MA13.03 Impact of a Tobacco Endgame Intervention on Lung Cancer Mortality in 185 Countries: A Population Birth Cohort Simulation Study
Authors: J. Rey Brandariz, H. Rumgay, O. Ayo-Yusuf, R. Edwards, F. Islami, S. Liu, M. Pérez-Ríos, P.C. Rodrigues Pinto Corrêa, A. Ruano-Ravina, I. Soerjomataram
Journal: Journal of Thoracic Oncology (2024)
OA17.05 A Randomized Controlled Trial of a Digital Lung Health Intervention to Facilitate Smoking Cessation and Lung Cancer Screening
Authors: M. Cooley, N. Xiong, E. Mazzola, M. Nayak, R. DeMarco, A. Borondy-Kitts, M. Blazey, M. Healey, C.-F.J. Yang, P. Castaldi, S. Kim
Journal: Journal of Thoracic Oncology (2024)
OA04.05 SHR-A1921, A TROP-2 Targeted Antibody-Drug Conjugate (ADC), In Patients (pts) with Advanced Small-Cell Lung Cancer (SCLC)
Authors: J. Wang, L. Wu, X. Li, N. Xing, S. Zhang, Z. Song, L. Chen, Q. Dang, C. Liu, Y. Li, H. XU, J. Zhong, Y. Wu, Z. Lin, Z. Zhang, S. Wang
Journal: Journal of Thoracic Oncology (2024)
OA15.03 Clinicogenomic Landscape of Lymph Node Metastases in TRACERx
Authors: T. Karasaki, M. Al Bakir, A. Huebner, J.R.M. Black, C. Abbosh, N. McGranahan, A.M. Frankell, M. Jamal-Hanjani, C. Swanton
Journal: Journal of Thoracic Oncology (2024)
OA16.05 Trastuzumab Deruxtecan Monotherapy in Pretreated HER2-overexpressing Nonsquamous Non-Small Cell Lung Cancer: DESTINY-Lung03 Part 1
Authors: D. Planchard, H.R. Kim, T. Suksombooncharoen, R. Li, J. Samol, Y. Runglodvatana, K.-Y. Lee, G.-C. Chang, D. Kowalski, J.-Y. Han, S. Saw, Y. Huang, A. Sookprasert, E. Nakajima, J. Alfon, Y.-T. Chang, J.C.-H. Yang
Journal: Journal of Thoracic Oncology (2024)
MA01.08 Five-Year Clinical Outcomes of Perioperative Nivolumab and Chemotherapy in Stage III Non-Small-Cell Lung Cancer (NADIM Trial)
Authors: M. Provencio, E. Nadal, A. Insa, M.R. García Campelo, V. Calvo, R. Palmero, M. Lázaro, M. Dómine, M. Majem, D. Rodríguez - Abreu, A. Martínez-Martí, J. De Castro Carpeño, M. Cobo, R. Bernabé, N. Viñolas, I. Barneto, S. Viteri, A. Cruz-Bermúdez, A. Romero, B. Massutí
Journal: Journal of Thoracic Oncology (2024)
MA11.11 Benmelstobart, a PD-L1 Mab, Plus Anlotinib in EGFR+ Advanced NSCLC Patients Failed to Prior EGFR TKI Therapies:Phase II Results Update
Authors: M. Shi, P. Chen, L. Cui, Y. Yao, J. Wang, T. Zhou
Journal: Journal of Thoracic Oncology (2024)
MA01.11 Unveiling Gene Expression and Immune Contexture in Stage II/III NSCLC Patients Receiving Neoadjuvant Pembrolizumab and Chemotherapy
Authors: Y. Chen, Y. Su, R. Zhang, S. Wang, J. Zhang, X. Sun, G. Zhao, Q. Ou, J. You
Journal: Journal of Thoracic Oncology (2024)
MA09.05 Circulating Protein Signatures and Immune Cells Are Predictive and Prognostic Markers for Patients with NSCLC in the SAKK 17/18 Trial
Authors: A. Rigutto, Y. Feng, P. Shichkova, L. Raess, S. Schaer, R. Bruderer, M. Tognetti, M. Joerger, S. Hayoz, V. Somasundaram, N. Nuñez, N. Fournier, J. Lourenço, R. Gottardo, B. Becher, A. Addeo, A. Gupta, A. Curioni-Fontecedro
Journal: Journal of Thoracic Oncology (2024)
OA08.07 Sacituzumab Govitecan + Pembrolizumab + Carboplatin in 1L Metastatic Non-Small Cell Lung Cancer: The EVOKE-02 Study
Authors: J. Gray, J. Neal, J.D. Patel, S.V. Liu, N. Girard, M. Reck, F. Cappuzzo, M. Cobo Dols, N. Reguart, J. Fuentes Pradera, B.C. Cho, M. Li, S. Mekan, F. Safavi, N. Fernando, D. Karumanchi, M. Chisamore, E.B. Garon
Journal: Journal of Thoracic Oncology (2024)